SUSMED Co., Ltd. announced that it has received ¥200 million in equity round of funding on August 25, 2020. The transaction included participation from Sumitomo Corporation (TSE:8053).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
553 JPY | +2.79% | +2.98% | -58.58% |
2023 | SUSMED,Inc.(TSE:4263) added to S&P Global BMI Index | CI |
2022 | Walgreens Boots Alliance, Inc. Joins Sustainable Medicines Partnership | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.58% | 57.65M | |
-19.71% | 177B | |
-2.07% | 161B | |
+1.06% | 152B | |
+4.74% | 99.88B | |
+11.45% | 81.66B | |
+20.90% | 74.66B | |
-9.67% | 70.05B | |
-31.19% | 45.84B | |
-11.09% | 42.83B |
- Stock Market
- Equities
- 4263 Stock
- News SUSMED,Inc.
- SUSMED Co., Ltd. announced that it has received ¥200 million in funding from Sumitomo Corporation